Compared to Estimates, Alignment Healthcare (ALHC) Q4 Earnings: A Look at Key Metrics

Core Insights - Alignment Healthcare (ALHC) reported a revenue of $701.24 million for Q4 2024, marking a year-over-year increase of 50.7% [1] - The company's EPS for the same period was -$0.16, an improvement from -$0.25 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $677.04 million by 3.58%, and the EPS also surpassed the consensus estimate of -$0.18 by 11.11% [1] Financial Performance Metrics - Medical Benefit Ratio was reported at 87.5%, better than the five-analyst average estimate of 89.4% [4] - Health Plan Membership at the end of the quarter was 189,100, exceeding the average estimate of 185,005 from four analysts [4] - Revenues from Other sources were $9.46 million, surpassing the estimated $7.48 million, reflecting a 48.3% increase compared to the previous year [4] - Earned Premiums revenue was $691.79 million, compared to the estimated $668.26 million, also showing a 50.7% increase year-over-year [4] Stock Performance - Over the past month, shares of Alignment Healthcare have declined by 14.1%, while the Zacks S&P 500 composite decreased by 2.2% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]